• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似艰难梭菌感染患者的替代诊断率较高。

A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection.

作者信息

Jackson Melissa, Olefson Sidney, Machan Jason T, Kelly Colleen R

机构信息

*Department of Internal Medicine, Brown Alpert Medical School †Department of Orthopedics and Surgery, The Warren Alpert Medical School, Brown University §Lifespan Biostatistics Core, Lifespan Hospital System ∥Division of Gastroenterology, Women's Medicine Collaborative, Alpert Medical School of Brown University, Providence ‡Department of Psychology, University of Rhode Island, Kingston, RI.

出版信息

J Clin Gastroenterol. 2016 Oct;50(9):742-6. doi: 10.1097/MCG.0000000000000447.

DOI:10.1097/MCG.0000000000000447
PMID:26565971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4865457/
Abstract

GOALS

We evaluated a cohort of patients referred to our center for presumed recurrent Clostridium difficile infection (CDI) to determine final diagnoses and outcomes.

BACKGROUND

As rates of CDI have increased, more patients are diagnosed with recurrent CDI and other sequelae of the infection. Distinguishing symptomatic patients with CDI from those who are colonized with an alternative etiology of diarrheal symptoms may be challenging.

MATERIALS AND METHODS

We performed a retrospective review of 117 patients referred to our center for recurrent CDI between January 2013 and June 2014. Data collected included demographics, the referring provider, previous anti-CDI treatment, and significant medical conditions. In addition, we gathered data on atypical features of CDI and investigations obtained to investigate the etiology of symptoms. Outcomes included rates of alternative diagnoses and the accuracy of CDI diagnosis by the referral source.

RESULTS

The mean age was 61 years, and 70% were female. About 29 patients (25%) were determined to have a non-CDI diagnosis. Most common alternative diagnoses included irritable bowel syndrome (18 patients: 62%) and inflammatory bowel disease (3 patients:10%). The age was inversely correlated with the rate of non-CDI diagnosis (P=0.016). Of the remaining 88 (75%) patients with a confirmed diagnosis of CDI, 25 (28%) received medical therapy alone and 63 (72%) underwent fecal microbiota transplantation.

CONCLUSIONS

Among patients referred to our center for recurrent CDI, a considerable percentage did not have CDI, but rather an alternative diagnosis, most commonly irritable bowel syndrome. The rate of alternative diagnosis correlated inversely with age. Providers should consider other etiologies of diarrhea in patients presenting with features atypical of recurrent CDI.

摘要

目的

我们评估了一组因疑似复发性艰难梭菌感染(CDI)而转诊至本中心的患者,以确定最终诊断和结局。

背景

随着CDI发病率的上升,越来越多的患者被诊断为复发性CDI及该感染的其他后遗症。将有症状的CDI患者与因腹泻症状的其他病因定植的患者区分开来可能具有挑战性。

材料与方法

我们对2013年1月至2014年6月间因复发性CDI转诊至本中心的117例患者进行了回顾性研究。收集的数据包括人口统计学信息、转诊医生、既往抗CDI治疗情况以及重大疾病情况。此外,我们收集了CDI非典型特征的数据以及为调查症状病因所进行的检查。结局包括替代诊断的发生率以及转诊来源对CDI诊断的准确性。

结果

平均年龄为61岁,70%为女性。约29例患者(25%)被确定为非CDI诊断。最常见的替代诊断包括肠易激综合征(18例患者:62%)和炎症性肠病(3例患者:10%)。年龄与非CDI诊断率呈负相关(P=0.016)。其余88例(75%)确诊为CDI的患者中,25例(28%)仅接受药物治疗,63例(72%)接受了粪便微生物群移植。

结论

在因复发性CDI转诊至本中心的患者中,相当一部分患者并非CDI,而是有其他诊断,最常见的是肠易激综合征。替代诊断率与年龄呈负相关。对于表现出复发性CDI非典型特征的患者,医生应考虑腹泻的其他病因。

相似文献

1
A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection.疑似艰难梭菌感染患者的替代诊断率较高。
J Clin Gastroenterol. 2016 Oct;50(9):742-6. doi: 10.1097/MCG.0000000000000447.
2
Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.粪便微生物群移植治疗艰难梭菌感染后早期失败的预测因素:一项多中心研究
Am J Gastroenterol. 2016 Jul;111(7):1024-31. doi: 10.1038/ajg.2016.180. Epub 2016 May 17.
3
Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.炎症性肠病患者艰难梭菌感染的粪便微生物群移植结局
Dig Dis Sci. 2017 Oct;62(10):2870-2875. doi: 10.1007/s10620-017-4580-4. Epub 2017 Apr 27.
4
Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis.台湾南部某医学中心艰难梭菌感染:发生率、临床特征和预后。
J Microbiol Immunol Infect. 2010 Apr;43(2):119-25. doi: 10.1016/S1684-1182(10)60019-9.
5
Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results.26 例复发性艰难梭菌感染患者的粪便微生物群移植:方法和结果。
J Clin Gastroenterol. 2012 Feb;46(2):145-9. doi: 10.1097/MCG.0b013e318234570b.
6
Assessing colectomies due to Clostridium difficile infection: increases in the community, but not in the referral center.评估因艰难梭菌感染而进行的结肠切除术:社区发病率上升,但转诊中心无显著变化。
Am J Infect Control. 2012 Oct;40(8):778-80. doi: 10.1016/j.ajic.2011.09.010. Epub 2012 Jan 30.
7
Experience and Outcomes at a Specialized Clinical Practice.一家专业临床实践机构的经验与成果
Mayo Clin Proc Innov Qual Outcomes. 2017 May 19;1(1):49-56. doi: 10.1016/j.mayocpiqo.2017.05.002. eCollection 2017 Jul.
8
Clostridium difficile Infection in Hospitalized Cirrhotic Patients with Hepatic Encephalopathy.肝硬化合并肝性脑病住院患者中艰难梭菌感染。
J Gastrointestin Liver Dis. 2015 Dec;24(4):423-8. doi: 10.15403/jgld.2014.1121.244.csd.
9
Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.炎症性肠病患者艰难梭菌感染的流行病学、诊断及管理
Inflamm Bowel Dis. 2016 Jul;22(7):1744-54. doi: 10.1097/MIB.0000000000000793.
10
Comparison of Clostridium difficile isolates from individuals with recurrent and single episode of infection.感染复发个体与单次感染个体的艰难梭菌分离株比较。
Anaerobe. 2015 Jun;33:105-8. doi: 10.1016/j.anaerobe.2015.03.003. Epub 2015 Mar 11.

引用本文的文献

1
Clostridioides difficile infection promotes gastrointestinal dysfunction in human and mice post-acute phase of the disease.艰难梭菌感染可促进疾病急性后期人类和小鼠的胃肠道功能障碍。
Anaerobe. 2024 Jun;87:102837. doi: 10.1016/j.anaerobe.2024.102837. Epub 2024 Mar 26.
2
Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies.复发性艰难梭菌感染:当前的临床管理及基于微生物群的治疗方法
BioDrugs. 2023 Nov;37(6):757-773. doi: 10.1007/s40259-023-00617-2. Epub 2023 Jul 26.
3
Nutraceuticals and Enteric Glial Cells.营养保健品与肠神经胶质细胞。
Molecules. 2021 Jun 21;26(12):3762. doi: 10.3390/molecules26123762.
4
Faecal microbiota transplantation for infection: Four years' experience of the Netherlands Donor Feces Bank.粪便微生物群移植治疗 感染:荷兰供体粪便银行四年经验。
United European Gastroenterol J. 2020 Dec;8(10):1236-1247. doi: 10.1177/2050640620957765. Epub 2020 Sep 29.
5
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.SER-109,一种用于减少艰难梭菌感染后复发的研究性微生物组药物:来自 2 期试验的经验教训。
Clin Infect Dis. 2021 Jun 15;72(12):2132-2140. doi: 10.1093/cid/ciaa387.
6
Diarrhea after fecal microbiota transplantation for recurrent infection.粪便微生物群移植治疗复发性感染后出现腹泻。
CMAJ. 2019 May 21;191(20):E559-E561. doi: 10.1503/cmaj.181193.
7
Retrospective analysis of long-term gastrointestinal symptoms after Clostridium difficile infection in a nonelderly cohort.非老年患者艰难梭菌感染后长期胃肠道症状的回顾性分析。
PLoS One. 2018 Dec 17;13(12):e0209152. doi: 10.1371/journal.pone.0209152. eCollection 2018.
8
Predictors of Mortality Among a National Cohort of Veterans With Recurrent Infection.全国退伍军人复发性感染队列中死亡率的预测因素。
Open Forum Infect Dis. 2018 Jul 19;5(8):ofy175. doi: 10.1093/ofid/ofy175. eCollection 2018 Aug.
9
Experience and Outcomes at a Specialized Clinical Practice.一家专业临床实践机构的经验与成果
Mayo Clin Proc Innov Qual Outcomes. 2017 May 19;1(1):49-56. doi: 10.1016/j.mayocpiqo.2017.05.002. eCollection 2017 Jul.
10
A comprehensive approach for the patient with Clostridium difficile infection.针对艰难梭菌感染患者的综合治疗方法。
Rev Esp Quimioter. 2018 Sep;31 Suppl 1(Suppl 1):27-31.

本文引用的文献

1
Increased risk of functional gastrointestinal sequelae after Clostridium difficile infection among active duty United States military personnel (1998-2010).现役美国军人(1998-2010 年)在艰难梭菌感染后功能性胃肠道后遗症的风险增加。
Gastroenterology. 2015 Nov;149(6):1408-14. doi: 10.1053/j.gastro.2015.07.059. Epub 2015 Aug 7.
2
Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis.入院时产毒艰难梭菌定植与感染风险:系统评价和荟萃分析。
Am J Gastroenterol. 2015 Mar;110(3):381-90; quiz 391. doi: 10.1038/ajg.2015.22. Epub 2015 Mar 3.
3
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.
4
Diagnosis and treatment of Clostridium difficile in adults: a systematic review.成人艰难梭菌的诊断与治疗:系统评价。
JAMA. 2015 Jan 27;313(4):398-408. doi: 10.1001/jama.2014.17103.
5
Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection.初始艰难梭菌感染治疗策略的成本效益分析。
Clin Microbiol Infect. 2014 Dec;20(12):1343-51. doi: 10.1111/1469-0691.12805.
6
Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement.炎症性肠病中的粪便微生物群移植:热潮之外
Medicine (Baltimore). 2014 Oct;93(19):e97. doi: 10.1097/MD.0000000000000097.
7
Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options.艰难梭菌感染:流行病学、发病机制、危险因素及治疗选择
Scientifica (Cairo). 2014;2014:916826. doi: 10.1155/2014/916826. Epub 2014 Jun 1.
8
Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates.实时聚合酶链反应检测无症状艰难梭菌定植及艰难梭菌相关疾病发病率上升
Infect Control Hosp Epidemiol. 2014 Jun;35(6):667-73. doi: 10.1086/676433. Epub 2014 Apr 22.
9
Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection.感染后肠易激综合征:对肠道感染后慢性紊乱的机制性见解。
World J Gastroenterol. 2014 Apr 14;20(14):3976-85. doi: 10.3748/wjg.v20.i14.3976.
10
Clinical update for the diagnosis and treatment of Clostridium difficile infection.艰难梭菌感染的诊断与治疗临床进展
World J Gastrointest Pharmacol Ther. 2014 Feb 6;5(1):1-26. doi: 10.4292/wjgpt.v5.i1.1.